Worcester , Mass. Crescent Innovations Inc., a biomedical company with operations in Worcester , MA , received two Notices of Allowance from the U.S. Patent and Trademark Office this month. The patents are expected to issue soon.

"One patent relates to our technology to treat TMJ disorders, a key area of focus for us," said Al Prescott, President of Crescent Innovations. "Crescent Innovations has been committed to developing a non-surgical therapy for the 10 million Americans who suffer TMJ disorders ever since the company was founded." The technology was partially developed with a Phase 1 grant from the National Institute of Dental Craniofacial Research, and is the subject of a pending Phase 2 grant.

The second Notice relates to a method for producing a new biological polymer. "All of our technologies relate to biological polymers, which are naturally occurring large molecules," explained Prescott. "This second patent relates to a method for producing polyglutamic acid, a molecule which has show great promise for treating joint pain, and acting as a drug delivery mechanism." Crescent Innovations has several more patents pending for the use of polyglutamic acid.

Crescent Innovations Inc. is a biomedical company based in Worcester, MA, and is developing technologies to treat TMJ disorders, degenerative joint disease, bone disease, fractures, and more. The company has received a Phase 1 SBIR Grant from the National Institutes of Health, and has worked with Fortune 500 companies.

For more information about Crescent Innovations Inc., please visit:
www.crescentinnovations.com